DCLK1 Inhibition Sensitizes Colorectal Cancer Cells to Radiation Treatment
Open Access
- 1 December 2021
- journal article
- research article
- Vol. 10 (1), 23-33
- https://doi.org/10.22088/IJMCM.BUMS.10.1.23
Abstract
Colorectal cancer (CRC) is one of the most prevalent diagnosed cancers and a common cause of cancer-related mortality. Despite effective clinical responses, a large proportion of patients undergo resistance to radiation therapy. Therefore, the identification of efficient targeted therapy strategies would be beneficial to overcome cancer radioresistance. Doublecortin-like kinase 1 (DCLK1) is an ...Keywords
This publication has 44 references indexed in Scilit:
- Cancer and Radiation Therapy: Current Advances and Future DirectionsInternational Journal of Medical Sciences, 2012
- Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaksHematological Oncology, 2011
- E-Cadherin loss associated with EMT promotes radioresistance in human tumor cellsRadiotherapy and Oncology, 2011
- BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response MachineryJournal of Neuroscience, 2010
- γH2AX: a sensitive molecular marker of DNA damage and repairLeukemia, 2010
- The first 30 years of p53: growing ever more complexNature Reviews Cancer, 2009
- Doublecortin-like Kinase Controls Neurogenesis by Regulating Mitotic Spindles and M Phase ProgressionNeuron, 2006
- Radiation Sensitivity, H2AX Phosphorylation, and Kinetics of Repair of DNA Strand Breaks in Irradiated Cervical Cancer Cell LinesCancer Research, 2004
- Effects of ionizing radiation on cell cycle progressionRadiation and Environmental Biophysics, 1995
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976